EPO Patents = 2

Forward Citations = 1

Loading Chart...

11 inventors (with patents filed for the assignee):

Kazuhiro Matsuda (4 out of 7 patents)

Yuko Sasaki (2 out of 37 patents)

Yuko Shingu (2 out of 2 patents)

4. Koji Ichiyama (2 out of 2 patents)

5. Sachie Matsuda (2 out of 2 patents)

6. Ryo Harasawa (2 out of 2 patents)

7. Yoshihiro Nishida (2 out of 2 patents)

8. Norio Katayama (2 out of 2 patents)

9. Yasuo Endo (2 out of 2 patents)

10. Nobuo Nomura (2 out of 2 patents)

11. Yoshichika Arakawa (2 out of 3 patents)

4 patents: Sort by Forward Citations

1. 10870669 - Method for producing an isolated monoclonal antibody specifically binding to a glycolipid antigen of (2020-12-22),

2. 10232026 - Vaccine for mycoplasma infection (2019-03-19),

3. 9539209 - Vaccine for mycoplasma infection (2017-01-10),

4. 8367076 - [object Object] (2013-02-05),

Company Overview

M Bio Technology Inc. is a leading biotechnology company that specializes in developing innovative solutions for the healthcare industry. With a focus on research and development, the company aims to create cutting-edge products and technologies that improve patient outcomes and enhance quality of life. M Bio Technology Inc. is dedicated to advancing the field of biotechnology through their commitment to excellence and scientific innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#3,053 in Tokyo

#7,579 in Japan

Tokyo, Japan

M Bio Technology Inc.

Forward Citations = 1

11 inventors:

Kazuhiro Matsuda (4 out of 7 patents)

Yuko Sasaki (2 out of 37 patents)

Yuko Shingu (2 out of 2 patents)

4. Koji Ichiyama (2 out of 2 patents)

5. Sachie Matsuda (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: M Bio Technology Inc.. Retrieved from https://idiyas.com/company/m-bio-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]